FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15621411000001104: Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
55017301000001113 Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60498601000001118 Conjugated oestrogens 300microgram / Medroxyprogesterone 1.5mg modified-release tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Is a Conjugated oestrogens + Medroxyprogesterone true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tabletmodified-release.oral ontology form and route true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Is a Product containing conjugated estrogen and medroxyprogesterone false Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has active ingredient Conjugated estrogen false Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has active ingredient Medroxyprogesterone false Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has specific active ingredient Conjugated estrogen true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has specific active ingredient Medroxyprogesterone acetate true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Premique Low Dose tablets (Wyeth Laboratories) Is a True Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Inferred relationship Existential restriction modifier
Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram tablets 84 tablet Has VMP True Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start